AbbVie and Cerebras Systems partner to accelerate AI research

Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption

Read on PharmaTimes

Evotenix receives patent for gene synthesis method

Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms

Read on PharmaTimes

University launches hub for pregnant women with pre-existing medical conditions

Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions

Read on PharmaTimes

WHO recommends Veklury for high-risk patients

WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions

Read on PharmaTimes

Farxiga demonstrates success in preserved ejection fraction trial

DELIVER represents the largest ever trial to address heart failure with preserved ejection fraction

Read on PharmaTimes

1 2 3

Top of page

Industry News

Sarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us